Analyst Upgrades and Downgrades For the Week of August 26th

Wednesday, August 28th:

Upgrades (Wednesday, August 28, 2024):

• AeroVironment (AVAV)
  • Alembic Global Advisors: Neutral to Overweight, Price Target: $216
  • Robert W. Baird: Neutral to Outperform, Price Target: $161 to $220
• Concentrix (CNXC)
  • BofA Securities: Underperform to Neutral, Price Target: $65 to $85
• Delek Logistics Partners (DKL)
  • Citigroup: Neutral to Buy, Price Target: $44 to $45
• EastGroup (EGP)
  • Wells Fargo: Equal Weight to Overweight, Price Target: $179 to $214
• Kite Realty (KRG)
  • Wells Fargo: Underweight to Equal Weight, Price Target: $23 to $26
• Moderna (MRNA)
  • HSBC Securities: Reduce to Hold, Price Target: $82
• ArcelorMittal (MT)
  • Deutsche Bank: Hold to Buy, Price Target: $29 to $31
• Phillips Edison & Company (PECO)
  • Wells Fargo: Underweight to Equal Weight, Price Target: $34 to $37
• Illumina (ILMN)
  • Argus: Hold to Buy
• Grupo Aeroportuario del Pacifico (PAC)
  • BofA Securities: Neutral to Buy

Downgrades (Wednesday, August 28, 2024):

• Bank of Montreal (BMO)
  • Scotiabank: Sector Outperform to Sector Perform
  • BofA Securities: Buy to Neutral
• Gannett (GCI)
  • Citigroup: Neutral to Sell
• Semtech (SMTC)
  • Summit Insights: Buy to Hold
• Spire Global (SPIR)
  • Raymond James: Outperform to Market Perform
• Terreno Realty (TRNO)
  • Wells Fargo: Overweight to Equal Weight, Price Target: $71 to $75
• TransUnion (TRU)
  • Needham: Buy to Hold
• Lifecore Biomedical (LFCR)
  • Barrington Research: Outperform to Market Perform
• Cinemark (CNK)
  • Barrington Research: Outperform to Market Perform

Coverage Initiated (Wednesday, August 28, 2024):

• Agilent (A)
  • Wells Fargo: Overweight, Price Target: $157
• Arcutis Biotherapeutics (ARQT)
  • Jefferies: Buy, Price Target: $15
• Avantor (AVTR)
  • Wells Fargo: Overweight, Price Target: $30
• Bio-Rad Labs (BIO)
  • Wells Fargo: Equal Weight, Price Target: $340
• Bruker (BRKR)
  • Wells Fargo: Overweight, Price Target: $78
• Century Communities (CCS)
  • Seaport Research Partners: Neutral
• CareDx (CDNA)
  • Wells Fargo: Underweight, Price Target: $28
• CG Oncology (CGON)
  • ROTH MKM: Buy, Price Target: $65
• Diversified Energy Company plc (DEC)
  • KeyBanc Capital Markets: Overweight, Price Target: $18
• Danaher (DHR)
  • Wells Fargo: Equal Weight, Price Target: $280
• enGene Holdings (ENGN)
  • Oppenheimer: Outperform, Price Target: $30
• Exact Sciences (EXAS)
  • Wells Fargo: Overweight, Price Target: $75
• EyePoint Pharmaceuticals (EYPT)
  • Jefferies: Buy, Price Target: $15
• Fiserv (FI)
  • BTIG Research: Buy, Price Target: $200
• GCT Semiconductor (GCTS)
  • B. Riley Securities: Buy, Price Target: $8
• Genelux (GNLX)
  • ROTH MKM: Buy, Price Target: $10
• M/I Homes (MHO)
  • Seaport Research Partners: Neutral
• Mesa Laboratories (MLAB)
  • Wells Fargo: Underweight, Price Target: $120
• Maravai Life Sciences (MRVI)
  • Wells Fargo: Overweight, Price Target: $10
• Mettler-Toledo (MTD)
  • Wells Fargo: Equal Weight, Price Target: $1400
• Myriad Genetics (MYGN)
  • Wells Fargo: Overweight, Price Target: $35
• Nanobiotix (NBTX)
  • Guggenheim: Buy, Price Target: $12
• Replimune (REPL)
  • ROTH MKM: Buy, Price Target: $17
• Repligen (RGEN)
  • Wells Fargo: Overweight, Price Target: $180
• Avidity Biosciences (RNA)
  • Barclays: Overweight, Price Target: $63
• Revvity (RVTY)
  • Wells Fargo: Equal Weight, Price Target: $130
• SAB BIO (SABS)
  • Oppenheimer: Outperform, Price Target: $12
• Thermo Fisher (TMO)
  • Wells Fargo: Overweight, Price Target: $670
• TRI Pointe Homes (TPH)
  • Seaport Research Partners: Neutral
• VersaBank (VBNK)
  • Keefe Bruyette: Outperform
• Vista Energy (VIST)
  • BofA Securities: Buy, Price Target: $70
• Waters (WAT)
  • Wells Fargo: Overweight, Price Target: $380
• GeneDx (WGS)
  • Wells Fargo: Equal Weight, Price Target: $34
• Byrna Technologies (BYRN)
  • ROTH MKM: Buy, Price Target: $14
• EHang (EH)
  • UBS: Buy, Price Target: $22

Monday August 26th, Upgrades, Downgrades, and More

Upgrades

• American Homes 4 Rent (AMH)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Equal Weight to Overweight
  • Price Target: $36 to $42
• BJ’s Wholesale (BJ)
  • Brokerage Firm: JP Morgan
  • Ratings Change: Underweight to Neutral
  • Price Target: $76 to $78
• Camden Property (CPT)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Underweight to Equal Weight
  • Price Target: $104 to $127
• Kymera Therapeutics (KYMR)
  • Brokerage Firm: Wolfe Research
  • Ratings Change: Peer Perform to Outperform
  • Price Target: $65
• Mid-America Apartment Communities (MAA)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Equal Weight to Overweight
  • Price Target: $138 to $174
• Ollie’s Bargain Outlet (OLLI)
  • Brokerage Firm: Gordon Haskett
  • Ratings Change: Accumulate to Buy
  • Price Target: $105 to $107
• Petrobras (PBR)
  • Brokerage Firm: Morgan Stanley
  • Ratings Change: Equal-Weight to Overweight
  • Price Target: $18 to $20
• Xcel Energy (XEL)
  • Brokerage Firm: Argus
  • Ratings Change: Hold to Buy
  • Price Target: $68
• Target (TGT)
  • Brokerage Firm: Daiwa Securities
  • Ratings Change: Neutral to Outperform

Downgrades

• Compania Cervecerias Unidas (CCU)
  • Brokerage Firm: Goldman
  • Ratings Change: Neutral to Sell
  • Price Target: $10.5
• Enova International (ENVA)
  • Brokerage Firm: Janney
  • Ratings Change: Buy to Neutral
• Equity Residential (EQR)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Overweight to Equal Weight
  • Price Target: $69 to $77
• Invitation Homes (INVH)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Overweight to Equal Weight
  • Price Target: $37 to $38
• MoonLake Immunotherapeutics (MLTX)
  • Brokerage Firm: Wolfe Research
  • Ratings Change: Outperform to Peer Perform
• Oaktree Specialty Lending Corp (OCSL)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Overweight to Equal Weight
  • Price Target: $18 to $17
• Premier (PINC)
  • Brokerage Firm: The Benchmark Company
  • Ratings Change: Buy to Hold
• BlackRock TCP Capital (TCPC)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Equal Weight to Underweight
  • Price Target: $8.5 to $8
• Wayfair (W)
  • Brokerage Firm: Argus
  • Ratings Change: Buy to Hold
• Kellanova (K)
  • Brokerage Firm: DA Davidson
  • Ratings Change: Buy to Neutral
  • Price Target: $80 to $83.5
• Pinduoduo (PDD)
  • Brokerage Firm: Macquarie
  • Ratings Change: Outperform to Neutral

Coverage Initiated

• Cormedix (CRMD)
  • Brokerage Firm: Rodman & Renshaw
  • Ratings Change: Buy
  • Price Target: $13
• Summit Materials (SUM)
  • Brokerage Firm: Morgan Stanley
  • Ratings Change: Overweight
  • Price Target: $51
• Light & Wonder (LNW)
  • Brokerage Firm: Maxim Group
  • Ratings Change: Buy
  • Price Target: $144
• JAKKS Pacific (JAKK)
  • Brokerage Firm: Maxim Group
  • Ratings Change: Buy
  • Price Target: $46